Role of Protein Phosphatase-1 in Cerebral Ischemia and Cell Death

蛋白磷酸酶 1 在脑缺血和细胞死亡中的作用

基本信息

批准号：
8415918
负责人：
HUGH C HEMMINGS
金额：
$ 34.75万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-02-15 至 2015-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8415918
关键词：
Address Apoptosis Apoptotic Attention Attenuated BCL2 gene Brain Calcium/calmodulin-dependent protein kinase Canis familiaris Catalytic Domain Cell Culture Techniques Cell Death Cell Survival Cell physiology Cells Cerebral Ischemia Cessation of life Clinical Co-Immunoprecipitations Complex Development Enzymes Family suidae Foundations Glucose Glutamate Receptor Glutamates Goals Health Healthcare Heart Arrest Hippocampus (Brain)Holoenzymes Hour Hydrogen Peroxide Impairment In Vitro Ischemia Lead Link Mass Fragmentography Mass Spectrum Analysis Mediator of activation protein Medical Medical Economics Membrane Modeling Molecular N-Methylaspartate Na(+)-K(+)-Exchanging ATPase Necrosis Nervous System Trauma Neurologic Neurons Nitric Oxide Synthase Nitrogen Oxygen Pathway interactions Peptide Hydrolases Phosphorylation Physiological Play Process Property Prosencephalon Protein Kinase Protein Kinase C Protein Phosphatase Inhibitor Protein Serine/Threonine Phosphatase Protein phosphatase Proteins Proteomics Reagent Regulation Reperfusion Therapy Research Proposals Resuscitation Role Scaffolding Protein Second Messenger Systems Shotguns Signal Pathway Signal Transduction Signal Transduction Pathway Simulate Site Specificity Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Testing Translations base brain cell calmodulin-dependent protein kinase II cell growth regulation cell injury deprivation design economic impact excitotoxicity genetic regulatory protein in vivo inhibitor/antagonist member neuroblastoma cell novel prevent protein phosphatase inhibitor-1 reconstitution research study response second messenger small molecule social tandem mass spectrometry therapeutic target voltage

项目摘要

DESCRIPTION (provided by applicant): Global cerebral ischemia due to cardiac arrest results in debilitating neurological impairment necessitating costly long-term health care. Despite this major clinical and economic impact, there is currently no specific medical therapy. Global cerebral ischemia is associated with extensive necrotic and apoptotic cell death; these processes are tightly regulated by several mechanisms, including a critical role for protein phosphorylation. While the involvement of protein kinases in the control of cell death in global cerebral ischemia is well established, the role of protein phosphatases has received relatively little attention. Protein phosphatase-1 is a member of the serine/threonine protein phosphatase subfamily that has been implicated in the regulation of cell death. We have identified and purified several novel multimeric forms of protein phosphatase-1 in mammalian brain. The activity of one of these, termed protein phosphatase-1IC (PP-1IC), is activated in vivo in pig and dog models of global cerebral ischemia as well as in cell culture models of ischemia. Based on these novel findings, we hypothesize that PP-1IC is a component of the signal transduction pathways that link global cerebral ischemia to cell death. In order to determine the mechanisms of activation and the role of PP-1IC in global cerebral ischemia, we propose to purify and characterize the PP-1IC holoenzyme from control and ischemic pig forebrain following cardiac arrest with resuscitation and reperfusion. The molecular compositions of native PP-1IC purified from control and ischemic brain will be determined by mass spectrometry, and the mechanisms of PP-1IC regulation will be studied by reconstitution of the identified components in vitro. Specific membrane permeable inhibitors of PP-1 and other reagents will be developed and used to determine the role of PP-1IC as a mediator of cell death in cell culture models of cerebral ischemia. The mechanisms of ischemic activation of PP-1IC will be investigated based on the hypothesis that the Ca2+regulated protein kinases, Ca2????dependent protein kinase II (CaMKII) and/or protein kinase C4 (PKC4) function as upstream regulators. These studies will elucidate physiological and pathophysiological mechanisms that regulate native PP-1 holoenzyme activity in brain and define the role of PP-1 in the control of cell death in global cerebral ischemia. This functional proteomics approach is targeted to the development of rational mechanism-based therapies to attenuate ischemic brain cell death, with a long-term goal of clinical translation.

描述（由申请人提供）：由于心脏骤停导致的全球脑缺血导致神经系统损害衰弱，因此需要昂贵的长期医疗保健。尽管存在这种重大的临床和经济影响，但目前尚无特定的医疗疗法。全球脑缺血与广泛的坏死和凋亡细胞死亡有关。这些过程受到多种机制的严格调节，包括蛋白质磷酸化的关键作用。尽管蛋白激酶在全球脑缺血中控制细胞死亡的涉及良好，但蛋白质磷酸酶的作用却相对较少。蛋白质磷酸酶-1是丝氨酸/苏氨酸蛋白磷酸酶亚科的成员，与细胞死亡的调节有关。我们已经确定并纯化了哺乳动物脑中蛋白质磷酸酶-1的几种新型多聚体形式。其中一种称为蛋白质磷酸酶-1IC（PP-1IC）的活性在全球脑缺血的猪和狗模型以及缺血细胞培养模型中被体内激活。基于这些新颖的发现，我们假设PP-1IC是将全局脑缺血与细胞死亡联系起来的信号转导途径的组成部分。为了确定激活的机制和PP-200在全球脑缺血中的作用，我们建议通过复苏和再灌注后心脏骤停后的对照和缺血性猪的前脑纯化和表征PP-1IC全酶。从对照和缺血大脑中纯化的天然PP-1IC的分子组成将由质谱法确定，PP-1IC调节的机制将通过重新建立在体外确定的组件来研究。将开发PP-1和其他试剂的特定膜可渗透抑制剂，并用于确定PP-1IC作为细胞死亡的介体在脑缺血细胞培养模型中的作用。 PP-1IC缺血性激活的机制将基于以下假设：Ca2+调节的蛋白激酶Ca2 ????依赖性蛋白激酶II（CAMKII）和/或蛋白激酶C4（PKC4）作为上游调节剂起作用。这些研究将阐明调节大脑中天然PP-1全酶活性的生理和病理生理机制，并确定PP-1在控制全球脑缺血中细胞死亡中的作用。这种功能蛋白质组学方法的目标是开发基于理性机制的疗法，以减轻缺血性脑细胞死亡，并具有临床翻译的长期目标。